Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity

Endocrinology

Volumn 141, Issue 9, 2000, Pages 3098-3103

  Conover, C A ^a   Bale, L K ^a   Durham, S K ^b   Powell, D R ^b  

^a MAYO CLINIC   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINO 2 METHYLPROPIONIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; DODECYL SULFATE SODIUM; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POLYACRYLAMIDE GEL; PROLINE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; THREONINE; TRITIUM;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; HORMONE ACTION; IMMUNOPRECIPITATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 0034455565     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.9.7660     Document Type: Article

References (36)

1. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)
2. Insulin-like growth factor binding proteins in the human circulation: A review
3. Insulin-like growth factors and their binding proteins: Biological actions
4. Cellular actions of insulin-like growth factor binding protein-3
5. Editorial: Growth inhibition by insulin-like growth factor (IGF) binding protein-3: What's IGF got to do with it?
6. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
7. An acid-stable insulin-like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cells
8. Structural and biological characterization of bovine insulin-like growth factor binding protein-3
9. An acid-stable insulin-like growth factor (IGF)-binding prorein from pig serum inhibits binding of IGF-I and IG F-II to vascular endothelial cells
10. Insulin-like growth factor receptors and binding proteins
11. Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I: Pivotal role for insulin receptor substrate-2
12. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
13. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
14. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3
15. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I
16. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism
17. Insulin-like growth factor-binding protein enhancement of Insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
18. IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells
19. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid
20. Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: Effect of exogenous IGFBP-3 on IGF-1 action
21. Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues
22. Insulin-like growth factor binding proteins as mediators of IGF-I effects on colon cancer cell proliferation
23. Factors regulating insulin-like growth factor binding protein-3 binding, processing, and potentiation of insulin-like growth factor action
24. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis
25. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
26. A synthetic inhibitor of the mitogen-activated protein kinase cascade
27. Molecular cloning and identification of a serine/threonine protein kinase of the secondmessenger subfamily
28. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
29. Mechanism of activation of protein kinase B by insulin and IGF-1
30. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
31. Okadaic acid: A new probe for the study of cellular regulation
32. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
33. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity
34. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth
35. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
36. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9